Nevro Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 02, 2022 at 08:51 pm
Share
Nevro Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 100.47 million compared to USD 93.21 million a year ago. Net income was USD 81.51 million compared to net loss of USD 50.08 million a year ago. Basic earnings per share from continuing operations was USD 2.3 compared to basic loss per share from continuing operations of USD 1.44 a year ago. Diluted earnings per share from continuing operations was USD 2.22 compared to diluted loss per share from continuing operations of USD 1.44 a year ago.
For the nine months, sales was USD 292.52 million compared to USD 284.15 million a year ago. Net income was USD 22.19 million compared to net loss of USD 101.23 million a year ago. Basic earnings per share from continuing operations was USD 0.63 compared to basic loss per share from continuing operations of USD 2.91 a year ago. Diluted earnings per share from continuing operations was USD 0.63 compared to diluted loss per share from continuing operations of USD 2.91 a year ago.
Nevro Corp. is a global medical device company. The Company is focused on delivering solutions that continue to set the standard for enduring patient outcomes in chronic pain treatment. Its comprehensive HFX spinal cord stimulation 3 (SCS) platform includes the Senza SCS system and support services for the treatment of chronic pain of the trunk and limb and painful diabetic neuropathy. It has developed and commercialized its HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain, with the Senza HFX iQ platform. Its HFX solution delivers a range of waveforms, including its paresthesia-free 10 kHz Therapy. Its 10 kHz Therapy is designed to deliver neuromodulation solutions for treating chronic pain. Its products include Senza II SCS System, Senza Omnia SCS System, Senza Omnia upgrade, Omnia Powered by HFX Connect, Senza HFX iQ System, and Surpass Surgical Lead.